| Name | Title | Contact Details |
|---|---|---|
Mareshia Donald |
Director, People and | Profile |
Aaron Kraus |
Sr. Director, HRBP for Technology and Data | Profile |
Britt Davis |
Senior Director, Human Resources | Profile |
Kate Wright |
Director, Cystic Fibrosis Global Marketing | Profile |
Kristin Warren |
Vice President of Procurement and Facilities | Profile |
BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland.
CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on developing therapies to treat metabolic diseases with high unmet medical need or serious rare and orphan diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline.
Taiga Biotechnologies is a privately-held developer of novel therapies for complex diseases including cancers, infectious agents such as HIV and influenza, and hematologic conditions.
Neurotrack is a digital health company dedicated to the development of non-invasive cognitive health assessment tools that will enable earlier and more effective evaluation of patients who may be at risk for cognitive decline, and help advance research of treatments for cognitive diseases, including Alzheimer`s.
iCyt Mission Technology is a Champaign, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.